Author
Joseph A. Baur
- Indexed works
- 30
- Total citations
- 12,846
- Active years
- 16
Collaborators
Works in the record
Nature 2006
Preprint · OA
Resveratrol improves health and survival of mice on a high-calorie diet
Science 2012
Preprint · OA
Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
The EMBO Journal 2007
Open access · OA
SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis
Cell Metabolism 2017
Open access · OA
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
The Journals of Gerontology Series A 2010
Open access · OA
Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
Journal of Clinical Investigation 2013
Preprint · OA
Rapalogs and mTOR inhibitors as anti-aging therapeutics
Nature 2023
Preprint · OA
CAR T therapy beyond cancer: the evolution of a living drug
PLoS ONE 2011
Open access · CC0
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
Molecular Metabolism 2021
Open access · CC-BY
Role of NAD+ in regulating cellular and metabolic signaling pathways
Nature Reviews Drug Discovery 2012
Preprint · OA
Are sirtuins viable targets for improving healthspan and lifespan?
Cell Metabolism 2018
Open access · OA
Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice
Scientific Reports 2011
Open access · CC-BY
SRT1720 improves survival and healthspan of obese mice
Redox Biology 2019
Open access · CC-BY
Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice
Mechanisms of Ageing and Development 2010
Preprint · OA
Resveratrol, sirtuins, and the promise of a DR mimetic
Aging 2009
Open access · CC-BY
Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy
Annals of the New York Academy of Sciences 2011
Open access · OA
Resveratrol and life extension
Nature Reviews Molecular Cell Biology 2024
Preprint · OA
Regulation of and challenges in targeting NAD+ metabolism
Nature Metabolism 2023
Open access · OA
NAD+ precursor supplementation prevents mtRNA/RIG-I-dependent inflammation during kidney injury
The Journals of Gerontology Series A 2011
Open access · OA
Challenges of Translating Basic Research Into Therapeutics: Resveratrol as an Example
Frontiers in Genetics 2012
Open access · CC-BY
Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2
Aging 2014
Open access · CC-BY
Rapamycin-induced metabolic defects are reversible in both lean and obese mice
Expert Reviews in Molecular Medicine 2013
Open access · OA
mTOR: more targets of resveratrol?
Endocrine Reviews 2023
Open access · OA
Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns
JCI Insight 2021
Open access · CC-BY
SIRT3 is required for liver regeneration but not for the beneficial effect of nicotinamide riboside
Aging 2018
Preprint · OA
Aging and drug discovery
The Journals of Gerontology Series A 2023
Open access · CC0
Drugs Targeting Mechanisms of Aging to Delay Age-Related Disease and Promote Healthspan: Proceedings of a National Institute on Aging Workshop
Cardiovascular Research 2021
Open access · OA
NAD+ metabolism and cardiometabolic health: the human evidence
Magnetic Resonance in Medicine 2024
Open access · CC-BY
Acute nicotinamide riboside supplementation increases human cerebral NAD + levels in vivo
Research Square 2020
Preprint · CC-BY
NAD+ flux is maintained in aged mice
Frontiers in Science 2026
Open access · CC-BY